Skip to main content
Clinical Trials/JPRN-UMIN000047026
JPRN-UMIN000047026Completed未知

Analysis of factors associated with blood pressure reduction and serum potassium elevation in hypertensive patients treated with esaxerenone (CS-3150) -Integrated analysis from CS-3150 phase 3 studies- - Analysis of factors associated with blood pressure reduction and serum potassium elevation in hypertensive patients treated with esaxerenone (CS-3150)

Daiichi Sankyo Co., Ltd.0 sites1,472 target enrollmentStarted: March 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
1,472